Compare PRPL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPL | PYPD |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 77.4M |
| IPO Year | 2015 | 2014 |
| Metric | PRPL | PYPD |
|---|---|---|
| Price | $0.70 | $4.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $1.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 203.9K | 48.8K |
| Earning Date | 05-05-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.22 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $487,877,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.69 | N/A |
| P/E Ratio | $1.55 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $2.30 |
| 52 Week High | $1.26 | $5.12 |
| Indicator | PRPL | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 43.87 |
| Support Level | $0.65 | $4.01 |
| Resistance Level | $0.74 | $4.38 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 55.07 | 17.60 |
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.